Form 8-K - Current report:
SEC Accession No. 0001839882-24-028650
Filing Date
2024-09-09
Accepted
2024-09-09 07:07:15
Documents
64
Period of Report
2024-09-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_090924.htm   iXBRL 8-K 33107
2 PRESS RELEASE ex99-01.htm EX-99.01 28348
3 USING SYNTHETIC BIOLOGY TO BATTLE MPOX ex99-02.htm EX-99.02 60719
4 GRAPHIC image_001.gif GRAPHIC 30687
5 GRAPHIC image_002.gif GRAPHIC 34626
6 GRAPHIC image_003.gif GRAPHIC 36535
7 GRAPHIC image_004.gif GRAPHIC 52131
8 GRAPHIC img001.jpg GRAPHIC 611611
9 GRAPHIC img002.jpg GRAPHIC 557521
10 GRAPHIC img003.jpg GRAPHIC 421765
11 GRAPHIC img004.jpg GRAPHIC 417165
12 GRAPHIC img005.jpg GRAPHIC 313940
13 GRAPHIC img006.jpg GRAPHIC 391990
14 GRAPHIC img007.jpg GRAPHIC 435472
15 GRAPHIC img008.jpg GRAPHIC 356090
16 GRAPHIC img009.jpg GRAPHIC 364091
17 GRAPHIC img010.jpg GRAPHIC 347798
18 GRAPHIC img011.jpg GRAPHIC 512673
19 GRAPHIC img012.jpg GRAPHIC 210369
20 GRAPHIC img013.jpg GRAPHIC 291656
21 GRAPHIC img014.jpg GRAPHIC 337615
22 GRAPHIC img015.jpg GRAPHIC 350903
23 GRAPHIC img016.jpg GRAPHIC 414006
24 GRAPHIC img017.jpg GRAPHIC 356646
25 GRAPHIC img018.jpg GRAPHIC 448209
26 GRAPHIC img019.jpg GRAPHIC 336026
27 GRAPHIC img020.jpg GRAPHIC 327450
28 GRAPHIC img021.jpg GRAPHIC 294445
29 GRAPHIC img022.jpg GRAPHIC 194208
30 GRAPHIC img025.jpg GRAPHIC 405145
31 GRAPHIC img026.jpg GRAPHIC 241805
32 GRAPHIC img027.jpg GRAPHIC 301280
33 GRAPHIC img028.jpg GRAPHIC 226812
34 GRAPHIC img030.jpg GRAPHIC 404705
35 GRAPHIC img031.jpg GRAPHIC 343616
36 GRAPHIC img032.jpg GRAPHIC 374157
37 GRAPHIC img033.jpg GRAPHIC 411291
38 GRAPHIC img034.jpg GRAPHIC 282738
39 GRAPHIC img035.jpg GRAPHIC 351124
40 GRAPHIC img036.jpg GRAPHIC 505117
41 GRAPHIC img037.jpg GRAPHIC 451541
42 GRAPHIC img038.jpg GRAPHIC 496076
43 GRAPHIC img039.jpg GRAPHIC 367015
44 GRAPHIC img040.jpg GRAPHIC 377382
45 GRAPHIC img041.jpg GRAPHIC 263944
46 GRAPHIC img042.jpg GRAPHIC 269850
47 GRAPHIC img044.jpg GRAPHIC 180719
48 GRAPHIC img045.jpg GRAPHIC 223250
49 GRAPHIC img046.jpg GRAPHIC 334076
50 GRAPHIC img047.jpg GRAPHIC 239680
51 GRAPHIC img048.jpg GRAPHIC 473154
52 GRAPHIC img049.jpg GRAPHIC 275635
  Complete submission text file 0001839882-24-028650.txt   22706426

Data Files

Seq Description Document Type Size
53 XBRL SCHEMA FILE tnxp-20240909.xsd EX-101.SCH 3024
54 XBRL LABEL FILE tnxp-20240909_lab.xml EX-101.LAB 34240
55 XBRL PRESENTATION FILE tnxp-20240909_pre.xml EX-101.PRE 22365
67 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-8k_090924_htm.xml XML 3543
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 241285777
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)